Repurposing Siddha mercurial drug for mild to moderate COVID-19 – Case series and exploration of its chemical profile

Saravana Shiva, Shanmugam Mari, Arul Amuthan, Ramalingam Shanmugam

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Repurposing Siddha mercurial drug for mild to moderate COVID-19 – Case series and exploration of its chemical profile'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Immunology and Microbiology